Liberty Wealth Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Liberty Wealth Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,000	Closed	-$13K	–	1216
2021 Q1	$13K	Hold	1,000	–	–	0.01%	548
2020 Q4	$13K	Hold	1,000	–	–	0.01%	544
2020 Q3	$14K	Hold	1,000	–	–	0.01%	470
2020 Q2	$15K	Buy	+1,000	New	+$10.2K	0.01%	430

Liberty Wealth Management's GNMK Position: Q2 2021 in Review

Liberty Wealth Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 1,000 shares — an estimated $13K sold.

Liberty Wealth Management first reported a position in GNMK in Q2 2020 and held it in 4 quarters. The position peaked at $15K in Q2 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Liberty Wealth Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Liberty Wealth Management sold 1,000 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $13K.
Liberty Wealth Management first reported a position in GenMark Diagnostics, Inc in Q2 2020 and held it in 4 quarters.
Liberty Wealth Management's GenMark Diagnostics, Inc position peaked at $15K in Q2 2020.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Liberty Wealth Management's 13F filing for Q2 2021, filed 13 Aug 2021.